Antifungal treatment | Fluconazole n (%) | Echinocandin n (%) | ||
OC | OC+ | OC− | OC+ | OC− |
All Candida (n=101) | 20 (19.8) | 29 (28.7) | 12 (11.8) | 40 (39.6) |
Treatment delay <12 hours (n=68) | 14 (20.5) | 18 (26.4) | 9 (13.2) | 27 (39.7) |
Treatment delay >12 hours (n=29) | 4 (13.7) | 9 (31.0) | 3 (10.3) | 13 (44.8) |
Central venous catheter (n=57) | 15 (26.3) | 14 (24.5) | 6 (10.5)* | 22 (38.6) |
Abdominal malignancy (n=31) | 11 (35.4) | 7 (22.6) | 2 (6.5)* | 10 (32.2) |
Candida albicans (n=73) | 17 (23.2) | 16 (21.9) | 12 (16.4) | 28 (38.3) |
Treatment delay <12 hours (n=48) | 12 (25.0) | 9 (18.8) | 9 (18.8) | 18 (37.6) |
Treatment delay >12 hours (n=22) | 3 (13.6) | 6 (27.2) | 3 (13.6) | 10 (45.4) |
Central venous catheter (n=43) | 15 (34.9) | 7 (16.2) | 6 (13.9)* | 15 (34.9) |
Abdominal malignancy (n=21) | 9 (42.9) | 4 (19.0) | 2 (9.5) | 6 (28.6) |
Non-albicans (n=28) | 3 (10.7) | 13 (46.4) | 0 (0) | 12 (42.9) |
Treatment delay <12 hours (n=20) | 2 (10.0) | 9 (45.0) | 0 (0) | 9 (45.0) |
Treatment delay >12 hours (n=7) | 1 (14.2) | 3 (42.9) | 0 (0) | 3 (42.9) |
Central venous catheter (n=15) | 1 (6.7) | 7 (46.7) | 0 (0) | 7 (46.7) |
Abdominal malignancy (n=9) | 2 (22.2) | 3 (33.3) | 0 (0) | 4 (44.4) |
*P<0.05.